Small Oncology stock -- CYTR# Stock
g*e
1 楼
Have been Searched promising oncology stock for a couple of day. I think
CYTR is a very good candidate:
Reasons for buy:
1. Cash rich $44 min comparing to this burn rate and market size.
2. Promising pipeline:
Three compounds: Aldoxorubicin, Tamibarotene and Bafetinib have been
advanced to Phase II. Four study results due on next year.
3. Insider buying:
Oct 21, 2012 PATTERSON SCOTT BRADFORDBeneficial Owner (10% or more)
115,000 Direct Purchase at $2.51 per share.
Oct 18, 2012 PATTERSON SCOTT BRADFORDBeneficial Owner (10% or more) 65
,000 Direct Purchase at $2.51 per share.
Oct 17, 2012 PATTERSON SCOTT BRADFORDBeneficial Owner (10% or more) 1,
200,000 Direct Purchase at $2.50 per share.
Just for your reference, please DD before investing.
Good luck!!
CYTR is a very good candidate:
Reasons for buy:
1. Cash rich $44 min comparing to this burn rate and market size.
2. Promising pipeline:
Three compounds: Aldoxorubicin, Tamibarotene and Bafetinib have been
advanced to Phase II. Four study results due on next year.
3. Insider buying:
Oct 21, 2012 PATTERSON SCOTT BRADFORDBeneficial Owner (10% or more)
115,000 Direct Purchase at $2.51 per share.
Oct 18, 2012 PATTERSON SCOTT BRADFORDBeneficial Owner (10% or more) 65
,000 Direct Purchase at $2.51 per share.
Oct 17, 2012 PATTERSON SCOTT BRADFORDBeneficial Owner (10% or more) 1,
200,000 Direct Purchase at $2.50 per share.
Just for your reference, please DD before investing.
Good luck!!